logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Turku University Hospital

+35823130000
sanna.pick@tyks.fi
Source: Site record.
https://www.tyks.fi

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Turku University Hospital (Tyks) is a leading public teaching hospital and the second oldest continuously operating medical institution in the Nordic region, founded in 1756. Operating under the wellbeing services county of Southwest Finland (Varha), the facility provides highly specialized healthcare to nearly 500,000 residents.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Trial-derived.
52Total Trials
Source: Trial-derived.
18Recruiting Trials
Source: Trial-derived.
24Active Trials
Source: Trial-derived.
19Completed Trials
Source: Trial-derived.
83Unique Conditions
Source: Trial-derived.
110Unique Sponsors

Conditions

Source: Trial-derived. Acute Lymphoblastic Leukemia (ALL) (2)Source: Trial-derived. Adolescent Idiopathic Scoliosis (2)Source: Trial-derived. Fabry Disease (2)Source: Trial-derived. Leukemia, Acute Lymphoblastic (2)Source: Trial-derived. Pain, Postoperative (2)Source: Trial-derived. Prostate Cancer (2)Source: Trial-derived. Acute Kidney Injury Due to Sepsis (1)Source: Trial-derived. Acute Lymphoblastic Leukemia in Remission (1)

Sponsors

Source: Trial-derived. Turku University Hospital (21)Source: Trial-derived. University of Turku (11)Source: Trial-derived. Helsinki University Central Hospital (4)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. University of Helsinki (4)Source: Trial-derived. Kuopio University Hospital (3)Source: Trial-derived. Stichting Hemato-Oncologie voor Volwassenen Nederland (3)Source: Trial-derived. Australian & New Zealand Children's Haematology/Oncology Group (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom